Ameriprise Financial Inc Lipocine Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.3 - $0.58 $33 - $63
-110 Reduced 0.25%
44,000 $14,000
Q4 2022

Feb 14, 2023
BUY
$0.37 - $8.65 $40 - $951
110 Added 0.25%
44,110 $17,000
Q3 2022

Nov 14, 2022
SELL
$0.49 - $7.65 $11,025 - $172,125
-22,500 Reduced 33.83%
44,000 $20,000
Q4 2021

Feb 14, 2022
SELL
$0.99 - $1.2 $336,105 - $407,400
-339,500 Reduced 83.62%
66,500 $66,000
Q3 2021

Nov 15, 2021
SELL
$1.08 - $1.49 $218,160 - $300,980
-202,000 Reduced 33.22%
406,000 $443,000
Q2 2021

Aug 16, 2021
SELL
$1.17 - $1.59 $109,980 - $149,460
-94,000 Reduced 13.39%
608,000 $851,000
Q1 2021

May 17, 2021
SELL
$1.38 - $2.28 $42,780 - $70,680
-31,000 Reduced 4.23%
702,000 $1.06 Million
Q4 2020

Feb 12, 2021
SELL
$1.2 - $1.69 $63,600 - $89,570
-53,000 Reduced 6.74%
733,000 $997,000
Q3 2020

Nov 16, 2020
SELL
$1.21 - $2.23 $3,025 - $5,575
-2,500 Reduced 0.32%
786,000 $1.11 Million
Q2 2020

Aug 14, 2020
SELL
$0.42 - $1.26 $642 - $1,926
-1,529 Reduced 0.19%
788,500 $994,000
Q1 2020

May 15, 2020
BUY
$0.32 - $0.77 $86,281 - $207,614
269,629 Added 51.81%
790,029 $269,000
Q4 2019

Feb 14, 2020
SELL
$0.32 - $3.15 $23,360 - $229,950
-73,000 Reduced 12.3%
520,400 $200,000
Q3 2019

Nov 14, 2019
BUY
$1.79 - $3.33 $35,352 - $65,767
19,750 Added 3.44%
593,400 $1.66 Million
Q2 2019

Aug 14, 2019
SELL
$1.43 - $2.32 $184,112 - $298,700
-128,750 Reduced 18.33%
573,650 $1.12 Million
Q1 2019

May 15, 2019
BUY
$1.46 - $2.33 $200,020 - $319,210
137,000 Added 24.23%
702,400 $1.62 Million
Q4 2018

Feb 14, 2019
BUY
$1.07 - $1.63 $343,363 - $523,066
320,900 Added 131.25%
565,400 $721,000
Q3 2018

Nov 14, 2018
BUY
$1.31 - $1.63 $108,730 - $135,290
83,000 Added 51.39%
244,500 $337,000
Q2 2018

Aug 14, 2018
BUY
$1.06 - $1.78 $106 - $178
100 Added 0.06%
161,500 $210,000
Q1 2018

May 15, 2018
SELL
$1.18 - $3.46 $1,180 - $3,460
-1,000 Reduced 0.62%
161,400 $247,000
Q4 2017

Feb 12, 2018
BUY
$3.36 - $4.35 $3,360 - $4,350
1,000 Added 0.62%
162,400 $559,000
Q3 2017

Nov 07, 2017
BUY
$3.67 - $4.19 $592,338 - $676,266
161,400
161,400 $641,000

About Lipocine Inc.

LPCN Quotes by TradingView
  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $433M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email